Chester County News and Community Website
NEWTOWN, PA — Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company, recently announced that the first patient has been dosed in the Company’s Phase 1/2a trial evaluating narazaciclib combined …
Onconova Therapeutics Doses First Patient in Phase 1/2a Trial of Narazaciclib Combined with Letrozole in Endometrial Cancer Read More
PHILADELPHIA, PA — Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic medicines company, reported financial results for the first quarter ended March 31, 2023 and provided recent business highlights.
Passage Bio Reports First Quarter 2023 Financial Results, Provides Recent Business Highlights Read More
MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company, announced financial results for the first quarter ended March 31, 2023, and provided recent corporate updates.
Galera Reports First Quarter 2023 Financial Results, Recent Corporate Updates Read More
YARDLEY, PA — Optinose (NASDAQ: OPTN), a pharmaceutical company, reported financial results for the quarter ended March 31, 2023, and provided operational updates.
Optinose Reports First Quarter 2023 Financial Results, Operational Updates Read More
BERWYN, PA — Annovis Bio, Inc. (NYSE: ANVS), a clinical-stage drug platform company, announced first quarter financial results for the period ended March 31, 2023, and reviewed recent accomplishments.
Annovis Bio Announces First Quarter 2023 Financial Results, Provides Corporate Update Read More
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company, recenlty reported financial results for the first quarter ended March 31, 2023, and provided a business update.
Cabaletta Bio Reports First Quarter 2023 Financial Results, Provides Business Update Read More
KING OF PRUSSIA, PA — Vertex, Inc. (NASDAQ: VERX) announced financial results for its first quarter ended March 31, 2023.
Vertex Announces First Quarter 2023 Financial Results Read More
MALVERN, PA — Vishay Intertechnology, Inc., (NYSE: VSH) this week announced results for the fiscal first quarter ended April 1, 2023.
Vishay Intertechnology Reports First Quarter 2023 Results Read More
PHILADELPHIA, PA — Amicus Therapeutics (Nasdaq: FOLD) this week announced financial results for the first quarter ended March 31, 2023.
Amicus Therapeutics Announces First Quarter 2023 Financial Results, Corporate Updates Read More
NEWARK, DE — Artesian Resources Corporation (Nasdaq: ARTNA) this week announced that revenues for the first quarter of 2023 were $22.5 million, a $0.3 million, or 1.4% increase, compared to …
Artesian Resources Corporation Reports First Quarter 2023 Results Read More